These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36074967)

  • 21. Correlation between serum cystatin C and lipid level in patients with chronic heart failure.
    Ni F; Xiang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 48(1):34-39. PubMed ID: 36935175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of sacubitril/valsartan on cardiac function in heart failure rabbits with preserved ejection fraction].
    Gao SY; Yao DH; Li JF; Xie QM; Jiang SC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):887-893. PubMed ID: 31744278
    [No Abstract]   [Full Text] [Related]  

  • 23. Diagnosis of chronic heart failure by the soluble suppression of tumorigenicity 2 and N-terminal pro-brain natriuretic peptide.
    Jin XL; Huang N; Shang H; Zhou MC; Hong Y; Cai WZ; Huang J
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28719009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined use of high-sensitivity ST2 and NT-proBNP for predicting major adverse cardiovascular events in coronary heart failure.
    Bai J; Han L; Liu H
    Ann Palliat Med; 2020 Jul; 9(4):1976-1989. PubMed ID: 32762223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative sST2 levels relate to myocardial remodeling and cardiac function improvement after cardiac valve surgery.
    Zhu Y; Pei L; Li N; Zhu Y
    ESC Heart Fail; 2024 Feb; 11(1):91-98. PubMed ID: 37820741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of brain-derived neurotrophic factor levels in patients with heart failure and reduced left ventricular ejection fraction.
    Barman HA; Şahin I; Atıcı A; Durmaz E; Yurtseven E; Ikitimur B; Okuyan E; Keleş I
    Anatol J Cardiol; 2019 Nov; 22(6):309-316. PubMed ID: 31789613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble ST2 protein and hospitalizations due to worsening chronic heart failure during a one-year follow-up in a population with reduced ejection fraction.
    Wojtczak-Soska K; Sakowicz A; Pietrucha T; Janikowski K; Lelonek M
    Adv Clin Exp Med; 2017 Sep; 26(6):931-938. PubMed ID: 29068593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The sST2 level is an independent influencing factor associated with atrial fibrillation in heart failure patients: a case-control study.
    Yan X; Guo Y; Li L; Wang Z; Li Z
    J Thorac Dis; 2022 May; 14(5):1578-1587. PubMed ID: 35693622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of blood urea nitrogen/creatinine ratio in the long-term prognosis of patients with acute myocardial infarction complicated with acute heart failure.
    Qian H; Tang C; Yan G
    Medicine (Baltimore); 2019 Mar; 98(11):e14845. PubMed ID: 30882678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between Levels of Serum Lipoprotein-Associated Phospholipase A2 and Soluble Suppression of Tumorigenicity 2 and Condition of Acute Heart Failure Patients and Their Predictive Value for Prognosis.
    Zhang J; Wang L; Zhao Z; Li L; Xia Y
    J Healthc Eng; 2021; 2021():1525190. PubMed ID: 34956555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure).
    O'Meara E; Prescott MF; Claggett B; Rouleau JL; Chiang LM; Solomon SD; Packer M; McMurray JJV; Zile MR
    Circ Heart Fail; 2018 May; 11(5):e004446. PubMed ID: 29748349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical impact of blood urea nitrogen, regardless of renal function, in heart failure with preserved ejection fraction.
    Yano M; Nishino M; Ukita K; Kawamura A; Nakamura H; Matsuhiro Y; Yasumoto K; Tsuda M; Okamoto N; Matsunaga-Lee Y; Egami Y; Tanouchi J; Yamada T; Yasumura Y; Tamaki S; Hayashi T; Nakagawa A; Nakagawa Y; Sotomi Y; Nakatani D; Hikoso S; Sakata Y;
    Int J Cardiol; 2022 Sep; 363():94-101. PubMed ID: 35777488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic role of urea-to-creatinine ratio in patients with acute heart failure syndrome: a case-control study.
    Sakr ARM; Gomaa GFE; Wasif SME; Eladawy AHH
    Egypt Heart J; 2023 Sep; 75(1):78. PubMed ID: 37668813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The partnership between renalase and ejection fraction as a risk factor for increased cardiac remodeling biomarkers in chronic heart failure patients.
    Stojanovic D; Mitic V; Stojanovic M; Petrovic D; Ignjatovic A; Stefanovic N; Cvetkovic T; Kocic G; Bojanic V; Deljanin Ilic M
    Curr Med Res Opin; 2020 Jun; 36(6):909-919. PubMed ID: 32297799
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of High-flux Hemodialysis With Narrative Care on Clinical Efficacy and Prognostic Quality of Life of Patients With Chronic Renal Failure.
    Weng Y; Hu L; Zhuang S; Shi Y; Xu C; Liu C
    Altern Ther Health Med; 2023 May; 29(4):164-169. PubMed ID: 36933248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ST2 elevation in heart failure, predictive of a high early mortality.
    Dalal JJ; Digrajkar A; Das B; Bansal M; Toomu A; Maisel AS
    Indian Heart J; 2018; 70(6):822-827. PubMed ID: 30580851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of serial measurements of blood urea nitrogen in ambulatory patients with chronic heart failure.
    Lombardi C; Carubelli V; Rovetta R; Castrini AI; Vizzardi E; Bondei I; Sciatti E; Manerba A; Benlodi E; Nodari S; Metra M
    Panminerva Med; 2016 Mar; 58(1):8-15. PubMed ID: 26154625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of high-sensitivity cardiac troponin I in heart failure patients with mid-range and reduced ejection fraction.
    Lokaj P; Spinar J; Spinarova L; Malek F; Ludka O; Krejci J; Ostadal P; Vondrakova D; Labr K; Spinarova M; Pavkova Goldbergova M; Miklikova M; Helanova K; Parenicova I; Jakubo V; Benesova K; Miklik R; Jarkovsky J; Ondrus T; Parenica J
    PLoS One; 2021; 16(7):e0255271. PubMed ID: 34329368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is cardiac biomarkers and left ventricular function affected by chronic kidney disease?
    Zand Parsa AF; Abdolahi A; Mahdavimazdeh M
    Indian Heart J; 2012; 64(5):479-83. PubMed ID: 23102386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum Cardiac Biomarkers in Asymptomatic Hemodialysis Patients: Role of Soluble Suppression of Tumorigenicity-2.
    Mancianti N; Maresca B; Palladino M; Salerno G; Cardelli P; Menè P; Barberi S
    Blood Purif; 2022; 51(2):155-162. PubMed ID: 33910194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.